
R3TA GLP3 — 20
Extended-supply vial for longer research protocols.
A once-weekly triple agonist — it acts on GIP, GLP-1 and glucagon receptors at the same time. One more pathway than tirzepatide, which is why it produces the largest weight reductions reported in any obesity trial programme to date.
Includes 10× sterile insulin syringes + 1 vial of bacteriostatic water, free with your order.
For research and educational use only. Not for human or veterinary consumption.
It does not replace a calorie deficit. Nothing in this catalogue does. It makes the deficit easy to hold instead of exhausting.
It does not protect your muscle. Rapid weight loss costs lean mass unless you eat enough protein and keep training. Plan for that from week one.
It does not work after you stop. Appetite returns. Weight regain after discontinuation is documented across the whole GLP class. Treat this as something you cycle deliberately, not something you take once.
Common, especially in the first days after each dose increase:
Less common:
Stop and see a doctor:
Trial discontinuation for side effects ran 4.1%, 6.9% and 11.3% across ascending doses. Most people who escalate slowly do not stop.
Draw past the line, tap out bubbles, push back to the line.
The AVERON Peptide Pen delivers 1 click = 0.01 mL. A U-100 insulin syringe delivers 1 unit = 0.01 mL. They are the same number. 20 clicks on the pen and 20 units on a syringe deliver exactly the same dose.
Maximum per injection: 100 units (1 mL)
10 mg vial + 1 mL bacteriostatic water = 10 mg/mL
| Dose | Volume | Units (U-100) |
|---|---|---|
| 1 mg | 0.10 mL | 10 |
| 2 mg | 0.20 mL | 20 |
| 4 mg | 0.40 mL | 40 |
| 6 mg | 0.60 mL | 60 (pen max — a syringe goes higher) |
✅ The 10 mg and 20 mg vials mix to the same strength, so the click numbers are identical whichever size you buy. Learn them once.
Inject the water slowly down the inside wall of the vial. Swirl gently, never shake. Wait until fully dissolved — it should be clear, with no particles.
Draw past the line, tap out bubbles, push back to the line.
The AVERON Peptide Pen delivers 1 click = 0.01 mL. A U-100 insulin syringe delivers 1 unit = 0.01 mL. They are the same number. 20 clicks on the pen and 20 units on a syringe deliver exactly the same dose.
Maximum per injection: 100 units (1 mL)
Once weekly, subcutaneous, same day each week. Abdomen or thigh, rotating sites.
| Weeks | Dose | Units (U-100) |
|---|---|---|
| 1–4 | 1 mg | 10 |
| 5–8 | 2 mg | 20 |
Cycle: run 8 weeks minimum to judge it. Trials ran 80 weeks. Most people cycle 12–20 weeks then take a break.
Never raise the dose early to finish a vial. The escalation exists to keep side effects manageable. Waste the remainder instead.
Honest note on this vial size: at 1 mg/week for four weeks then 2 mg for four, you'll use about 12 mg across an 8-week cycle. One 10 mg vial doesn't cover it, and its 4-week refrigerated window closes before you'd finish it anyway. Two vials is the real number.
Retatrutide has the strongest data of any compound in this catalogue after the approved GLP-1s. Five positive phase 3 readouts as of mid-2026, including TRIUMPH-1 (2,339 adults, 28.3% average loss at 12 mg over 80 weeks, with a BMI≥35 extension reaching 30.3% at 104 weeks). It is not approved anywhere — Lilly's filing is expected around 2027. What we supply is research-grade material, not a pharmaceutical product.
Athletes: unapproved substances fall under WADA S0. Prohibited in competition.
Every peptide batch we sell is tested by Janoshik Analytical, an independent laboratory. Every vial carries an internal AVERON batch code identifying the lot received; each lot is linked to its published Janoshik report. The report carries the manufacturer's submission/task number, not the AVERON code. Ask us or our driver which report covers your code and open it on the laboratory's own website before paying. In our own-driver zone, the team shows you the vial and the report for that batch before payment.
A lab report handed to you by a seller and a lab report you can verify yourself are not the same thing. That's why we publish ours.
View COA on Janoshik
Extended-supply vial for longer research protocols.

Once-weekly GLP-1 with the deepest trial record in its class
